Preparation of soluble immune response suppressor and macrophage-derived suppressor factor.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  1982-08-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-1759(82)90235-6PMID 6752280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism of action of macrophage-derived suppressor factor produced by soluble immune response suppressor-treated macrophages.

  1981cited by this paper
• Identification and initial characterization of a nonspecific suppressor factor (macrophage-SF) produced by soluble immune response suppressor (SIRS)-treated macrophages.

  1981cited by this paper
• Conversion of soluble immune response suppressor to macrophage-derived suppressor factor by peroxide.

  1981cited by this paper
• Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

  1976cited by this paper
• Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

  1976cited by this paper
• CELL-MEDIATED IMMUNE RESPONSES IN VITRO

  1974cited by this paper
• Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures.

  1974cited by this paper
• BIOLOGICAL EXPRESSIONS OF LYMPHOCYTE ACTIVATION

  1973cited by this paper
• IMMUNE RESPONSES IN VITRO

  1971cited by this paper

• Soluble Immune Response Suppressor (SIRS): Reassessing the immunosuppressant potential of an elusive peptide.

  2016cites this paper
• Ingested (Oral) SIRS Peptide 1-21 Suppresses Type 1 Diabetes in NOD Mice

  2008cites this paper
• Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokines.

  2007cites this paper
• Suppressive effect of actarit on IgA production in mice: activation of CD4+ suppressor T-cells in Peyer's patches.

  1995cites this paper
• Purification and partial characterization of a soluble suppressor factor from papillomavirus-infected patients.

  1991cites this paper
• Purification, characterization, and structural elucidation of the active moiety of the previously called "suppressor activating factor (SAF)".

  1990cites this paper
• Hormonal regulation of soluble immune response suppressor (SIRS): a possible role of SIRS in the maintenance of pregnancy.

  1990cites this paper
• Generation, Biology, and Assay of Efferent Lymphokines

  1988cites this paper
• The Pharmacology of Lymphocytes

  1988cites this paper
• Antipeptide antibody specific for the N-terminal of soluble immune response suppressor neutralizes concanavalin A and IFN-induced suppressor cell activity in an in vitro cytotoxic T lymphocyte response.

  1988cites this paper
• Characterization of monoclonal nonspecific suppressor factor (MNSF) with the use of a monoclonal antibody.

  1987cites this paper
• Functional analysis of antigen-nonspecific T-cell suppression. I. Effect of mitogen-induced T suppressor cells on helper-T-cell clones.

  1987cites this paper
• Beta-lactam antibiotics and human lymphocyte function: the in vitro effect on blastogenesis, lymphokine production and suppressor cell functions.

  1987cites this paper
• Cells involved in the immune response. XXXIV: Suppressor cells in the thymus of the immunized rabbit capable of secreting a factor which can suppress the secretion of antibodies from antibody-forming cells in vitro.

  1986cites this paper
• [Effect of T-cell mitogens and T-lymphocyte deficiency on splenic colony formation].

  1986cites this paper
• Peritoneal macrophages exposed to purified macrophage colony-stimulating factor (M-CSF) suppress mitogen- and antigen-stimulated lymphocyte proliferation.

  1986cites this paper
• Isolation and characterization of a monoclonal nonspecific suppressor factor (MNSF) produced by a T cell hybridoma.

  1986cites this paper
• Two different pathways of interferon mediated suppression of antibody secretion.

  1985cites this paper
• Production of soluble suppressor factors by herpes simplex virus-stimulated splenocytes from herpes simplex virus-immune mice

  1985cites this paper
• Production of the lymphokine soluble immune response suppressor (SIRS) during chronic experimental schistosomiasis mansoni.

  1985cites this paper
• ELISA for the detection of the lymphokine soluble immune response suppressor.

  1985cites this paper
• Suppression of a polyclonal B-cell response by supernatants from the murine autologous mixed lymphocyte reaction.

  1985cites this paper
• Inhibition of soluble immune response suppressor activity by growth factors.

  1985cites this paper
• Immune system in rheumatoid arthritis: possible implications in neoplasms.

  1985cites this paper
• Soluble immune response suppressor (SIRS) inhibits microtubule function in vivo and microtubule assembly in vitro.

  1984cites this paper
• Cellfree translation of the lymphokine soluble immune response suppressor (SIRS) and characterization of its mRNA.

  1984cites this paper
• Mouse B‐ and T‐Cell Colony Formation in Vitro

  1984cites this paper
• Identification and initial characterization of concanavalin A- and interferon-induced human suppressor factors: evidence for a human equivalent of murine soluble immune response suppressor (SIRS).

  1984cites this paper
• Modification of cellular protein sulfhydryl groups by activated soluble immune response suppressor.

  1984cites this paper
• Suppressor T cell activation by human leukocyte interferon.

  1983cites this paper
• Kinetic Analysis of Subset Growth and B‐Cell Activation in Pokeweed Mitogen‐Stimulated Cultures of Peripheral Blood Mononuclear Cells Depleted of or Enriched for OKT8+ Cells

  1983cites this paper
• Purification and initial characterization of the lymphokine soluble immune response suppressor.

  1983cites this paper